Biomarkers for the Detection of Thrombosis or Coagulation-Related Disorders and Their Applications
AssigneeYigong Ruisi Fujian Engineering Rescenter Co Ltd.
InventorZhe Lin
Life of this patent
Estimating the term…
Loading patent…
AssigneeYigong Ruisi Fujian Engineering Rescenter Co Ltd.
InventorZhe Lin
Estimating the term…
The present invention relates to the technical field of thrombosis and hemostasis-related disease detection technologies, and in particular to a biomarker and an application thereof in thrombotic and coagulation-related disorders detection. The biomarker comprises an activated peptide of Coagulation Factor XIII (FXIIIAP) and/or an A subunit of Coagulation Factor XIII (FXIIIA). The diagnostic kit provided by the present invention comprises a capture antibody and a detection antibody, which is a specific antibody prepared by using FXIIIAP as an antigen. The biomarker of the present invention has a promising application prospect of rapid screening and diagnosis of thrombotic and coagulation-related diseases, including strokes, can significantly improve the sensitivity and specificity of existing diagnostic methods, speculate the thrombus formation timing and extent, and can predict the severity and prognosis of the disease.
A biomarker for detecting thrombotic or coagulation-related disorders, characterized by comprising a blood coagulation factor 13 activation peptide or/and a blood coagulation factor 13 A subunit.
Dependencies are inferred from the claim text.